Table of Contents
Cover image
Two novel 123I-labeled small molecules targeting prostate-specific membrane antigen have shown potential for visualizing prostate cancer on SPECT/CT, as shown by these images 4 h after injection.
See page 380.
Two novel 123I-labeled small molecules targeting prostate-specific membrane antigen have shown potential for visualizing prostate cancer on SPECT/CT, as shown by these images 4 h after injection.
See page 380.
